Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Protein Expression and Purification|March 22, 2015
Efficient expression, purification and characterization of native human cystatin C in Escherichia coli periplasmYongjun Zhou, Yan Zhou, Jun Li, et al.Journal of Medicinal Chemistry|September 20, 2025
Discovery of Novel 4,5-Dihydropyrrolo[3,4-c]pyrazol-6(2H)-one-Based Tubulin Inhibitors Targeting Colchicine Binding Site with Potent Anti-Ovarian Cancer ActivityQuanwei Yu, Yujie Liu, Zhijia Wang, et al.Journal of Proteome Research|January 2, 2009
Proteomic profiling identifies aberrant epigenetic modifications induced by hepatitis B virus X proteinAiping Tong, Lantu Gou, Quek Choon Lau, et al.BMC Immunology|August 21, 2024
Antagonist anti-LIF antibody derived from naive human scFv phage library inhibited tumor growth in miceShengyan Zhao, Han Deng, Ying Lu, et al.Journal of Medicinal Chemistry|August 19, 2022
Design, Synthesis, and Bioevaluation of a Novel Hybrid Molecular Pyrrolobenzodiazepine-Anthracenecarboxyimide as a Payload for Antibody-Drug ConjugateWeirong Lai, Shengyan Zhao, Qinhuai Lai, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 3, 2014
Eradication of growth of HER2-positive ovarian cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate in mouse xenograft modelLin Yu, Yuxi Wang, Yuqin Yao, et al.Protein Expression and Purification|July 9, 2018
Expression of 5T4 extracellular domain fusion protein and preparation of anti-5T4 monoclonal antibody with high affinity and internalization efficiencyRuixue Wang, Qinhuai Lai, Ying Lu, et al.International Journal of Cancer|January 5, 2024
Non-IL-2-blocking anti-CD25 antibody inhibits tumor growth by depleting Tregs and has synergistic effects with anti-CTLA-4 therapyYujia Peng, Yuyin Fu, Hong Liu, et al.Journal of Molecular Medicine (Berlin, Germany)|September 19, 2015
Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-κB and proinflammatory cytokinesYangping Wu, Xiangzheng Chen, Xiaojun Ge, et al.Oncotarget|February 14, 2018
Promiximab-duocarmycin, a new CD56 antibody-drug conjugates, is highly efficacious in small cell lung cancer xenograft modelsLin Yu, Ying Lu, Yuqin Yao, et al.Pageof 5